Lippo China Resources Limited Reports HK$396.8 Million Revenue for First Half of 2025

Reuters
09/29
Lippo China Resources Limited Reports HK$396.8 Million Revenue for First Half of 2025

Lippo China Resources Limited reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded total revenue from contracts with customers of HK$396.8 million, up from HK$352.4 million in the prior-year period. Revenue from food manufacturing increased to HK$202.9 million from HK$166.4 million, while restaurant operations generated HK$187.8 million, compared to HK$179.5 million a year earlier. Revenue from provision of management services was HK$6.1 million, versus HK$6.5 million in the same period last year. The Group posted a net loss attributable to equity holders of HK$80.3 million for the period, an improvement from a net loss of HK$137.3 million for the same period in 2024. Loss for the period, including non-controlling interests, was HK$84.2 million, compared to HK$150.9 million previously. By geography, revenue from Hong Kong amounted to HK$130.2 million, up from HK$120.0 million. Revenue from the Republic of Singapore rose to HK$220.9 million from HK$220.9 million, while revenue from Mainland China was HK$1.0 million, down from HK$1.0 million, and revenue from Malaysia reached HK$10.4 million, up from HK$10.4 million. No outlook or guidance was included in the interim report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lippo China Resources Limited published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10